Region · organisational layer

South America

Resource-weighted markets where currency, policy and governance structure are first-order research inputs rather than background conditions.

Country markets 04 Alpha markets
Live constituents — Across region

Regions organise; countries define

There is no South America Structural Alpha Index and no South America Alpha Portfolio. Each market below carries its own Index and its own Portfolio.

The constellation

South America at true coordinates

South America · 4 markets

Coverage developing Active coverage
BR CL AR PE

Positions are the geographic coordinates of each market’s principal financial centre, and a shaded country is one FIBCOS covers. Both state coverage only.

Markets

04 Alpha markets

The tick sequence on each row is that market’s position on the FIBCOS Alpha Line: research, thesis, approval, Index, portfolio, performance.

01 Brazil BR · BRL · FIBCOS Brazil Structural Alpha Index Coverage Developing
02 Chile CL · CLP · FIBCOS Chile Structural Alpha Index Coverage Developing
03 Argentina AR · ARS · FIBCOS Argentina Structural Alpha Index Coverage Developing
04 Peru PE · PEN · FIBCOS Peru Structural Alpha Index Coverage Developing

Frameworks

Index and Portfolio status in this region

South America — Index and Portfolio status
MarketStructural Alpha IndexIndex statusAlpha PortfolioPortfolio statusBenchmark
BrazilBR FIBCOS Brazil Structural Alpha Index Coverage Developing FIBCOS Brazil Alpha Portfolio Not Yet Incepted Not established
ChileCL FIBCOS Chile Structural Alpha Index Coverage Developing FIBCOS Chile Alpha Portfolio Not Yet Incepted Not established
ArgentinaAR FIBCOS Argentina Structural Alpha Index Coverage Developing FIBCOS Argentina Alpha Portfolio Not Yet Incepted Not established
PeruPE FIBCOS Peru Structural Alpha Index Coverage Developing FIBCOS Peru Alpha Portfolio Not Yet Incepted Not established

Research context

Company-level research in this region cannot be separated from the macro and institutional environment. FIBCOS treats currency treatment and policy durability as gating questions, not footnotes.